SELECT * FROM `tbl_content` WHERE `c_type` = 'advertise' AND `c_status` = '1' AND `c_is_deleted` = '0' ORDER BY `c_order` desc LIMIT 3 Association of Biotechnology Led Enterprises

News

Aurobindo Pharma ties up with BIRAC to develop COVID-19 vaccine

ABLE Member and Hyderabad-headquartered pharma major Aurobindo Pharma  announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine.

Read More

Sep 17, 2020

By : Team ABLE

Bharat Biotech’s Covid Vaccine shows robust immune response in animal tests

India’s Covid Vaccine candidate COVAXIN™ (BBV152) shows demonstration of protective efficacy and immunogenicity in non-human primates

Read More

Sep 17, 2020

By : Team ABLE

“Biological E can make a billion doses of the vaccine a year,” Dr Maria Elena Bottazzi, associate dean, BCM National School of Tropical Medicine

In an interview to The Indian Express, Dr Maria Elena Bottazzi, said that Hyderabad-headquartered vaccine maker Biological E can help scale up production of an affordable Covid-19 vaccine.

Read More

Sep 17, 2020

By : Team ABLE

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford Covid-19 vaccine

SII, which has partnered with AstraZeneca for manufacturing the vaccine candidate for Covid-19, on September 15 submitted the recommendations of the Data and Safety Monitoring Board (DSMB), UK and DSMB, India, and requested for permission to restart enrolment in the clinical trial of the Covid Vaccine.

Read More

Sep 17, 2020

By : Team ABLE

Dr. Reddy’s signs MoU to receive 100 million doses of Russian Covid Vaccine Sputnik V vaccine

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and ABLE member, Dr. Reddy’s Laboratories Ltd (Dr. Reddy’s) have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.

Read More

Sep 17, 2020

By : Team ABLE

 

Archives

The GREEN BOOK

Indian Biotech Resources Guide June 2020

ABLE Webinar Series

October 30 at 4-5 PM